Stryker Co. (NYSE:SYK) Shares Purchased by Rodgers Brothers Inc.

Rodgers Brothers Inc. increased its position in shares of Stryker Co. (NYSE:SYK) by 14.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,217 shares of the medical technology company’s stock after purchasing an additional 150 shares during the quarter. Rodgers Brothers Inc.’s holdings in Stryker were worth $438,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the company. Cannell & Spears LLC raised its position in shares of Stryker by 1.0% in the fourth quarter. Cannell & Spears LLC now owns 4,697 shares of the medical technology company’s stock valued at $1,691,000 after buying an additional 45 shares during the last quarter. Summit Financial LLC raised its holdings in Stryker by 236.9% in the 4th quarter. Summit Financial LLC now owns 24,456 shares of the medical technology company’s stock valued at $8,826,000 after acquiring an additional 17,196 shares during the last quarter. Hoey Investments Inc. purchased a new position in Stryker in the 4th quarter worth approximately $125,000. AIA Group Ltd acquired a new position in shares of Stryker during the 4th quarter worth approximately $295,000. Finally, O Shaughnessy Asset Management LLC grew its position in shares of Stryker by 8.3% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 40,259 shares of the medical technology company’s stock valued at $14,495,000 after purchasing an additional 3,076 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on SYK shares. Barclays boosted their price objective on Stryker from $418.00 to $443.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Canaccord Genuity Group upped their price objective on shares of Stryker from $420.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Wells Fargo & Company lifted their target price on shares of Stryker from $427.00 to $435.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 29th. Argus set a $450.00 price target on shares of Stryker in a research note on Monday, February 3rd. Finally, The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a research report on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $421.90.

Insiders Place Their Bets

In related news, Director Allan C. Golston sold 2,458 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares in the company, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Performance

NYSE:SYK opened at $372.73 on Tuesday. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a fifty day simple moving average of $383.86 and a two-hundred day simple moving average of $374.41. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company has a market cap of $142.27 billion, a price-to-earnings ratio of 48.03, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the prior year, the business posted $3.46 EPS. As a group, equities analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.90%. Stryker’s dividend payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.